Swedish Orphan Biovitrum AB (PK) (BIOVF)
USOTC
News
Market Data
Register for real-time alerts, custom portfolio, and market movers
The current BIOVF market cap is 11.08B. The company's latest EPS is SEK 6.7982 and P/E is 4.60.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | |
| Total Revenue | 14.25B | 15.26B | 15.53B | 18.79B | 22.12B |
| Operating Income | 4.53B | 4.83B | 3.79B | 3.85B | 4.18B |
| Net Income | 3.3B | 3.25B | 2.68B | 2.64B | 2.41B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | |
| Total Assets | 45.66B | 48.28B | 48.66B | 52.5B | 74.03B |
| Total Liabilities | 28.73B | 28.08B | 25.46B | 25.97B | 40.16B |
| Total Equity | 16.93B | 20.21B | 23.2B | 26.53B | 33.87B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | |
| Operating | 3.63B | 5.21B | 5.47B | 4.67B | 4.47B |
| Investing | -21.69B | -3.96B | -367M | -1.48B | -21.9B |
| Financing | 15.78B | -1.57B | -4.47B | -2.99B | 17.01B |
| Market Cap | 11.08B |
| Price to Earnings Ratio | 4.60 |
| Price to Sales Ratio | 0.5 |
| Price to Cash Ratio | 12.26 |
| Price to Book Ratio | 0.33 |
| Dividend Yield | - |
| Shares Outstanding | 354.36M |
| Average Volume (1 week) | 149 |
| Average Volume (1 Month) | 1.15k |
| 52 Week Change | 8.88% |
| 52 Week High | 31.28 |
| 52 Week Low | 18.25 |
| Spread (Intraday) | 27.85 (62.33%) |
| Company Name | Swedish Orphan Biovitrum AB (PK) |
| Address |
tomtebodav��gen 23a, solna stockholm SE112 76 |
| Website | https://www.sobi.com |
| Industry | pharmaceutical diversified (H2) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
